Enfusion Balance Sheet Health

Financial Health criteria checks 6/6

Enfusion has a total shareholder equity of $96.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $134.9M and $38.8M respectively. Enfusion's EBIT is $11.2M making its interest coverage ratio -7. It has cash and short-term investments of $48.3M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-7x
CashUS$48.30m
EquityUS$96.18m
Total liabilitiesUS$38.76m
Total assetsUS$134.94m

Recent financial health updates

Recent updates

Why Private Equity Will Buyout Enfusion

Oct 29

Enfusion: Growth Should Accelerate In Coming Quarters

Aug 19

Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Aug 14
Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating

Jun 16

Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Mar 13
Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Feb 19
Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Enfusion: Product Is Sticky And Industry Is Huge

Jan 18

Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Jan 04
Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Dec 02
Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Enfusion: Still Bullish Considering Q3 EBITDA Beat

Nov 08

Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Oct 31
Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Enfusion Faces Cross-Currents In Investment Management Software Market

Aug 24

Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 11
Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Enfusion: Multiple Catalysts

Jun 20

Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 08
Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Feb 08
Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Enfusion brings on Shift4 Payments' Brad Herring as CFO

Dec 19

Enfusion Expands Offerings As Revenue Growth Decelerates

Oct 31

Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate

Oct 18
Enfusion, Inc. (NYSE:ENFN) Shares Could Be 49% Below Their Intrinsic Value Estimate

Enfusion gains after takeover report

Aug 31

Enfusion gets new interim CEO

Aug 22

Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Aug 12
Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Financial Position Analysis

Short Term Liabilities: ENFN's short term assets ($85.4M) exceed its short term liabilities ($23.6M).

Long Term Liabilities: ENFN's short term assets ($85.4M) exceed its long term liabilities ($15.2M).


Debt to Equity History and Analysis

Debt Level: ENFN is debt free.

Reducing Debt: ENFN had no debt 5 years ago.

Debt Coverage: ENFN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ENFN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies